Chemoradiation for locally advanced squamous cell carcinoma of the head and neck for organ preservation and palliation

Archives of Otolaryngology - Head and Neck Surgery

Volumn 127, Issue 12, 2001, Pages 1446-1450

  Poole, Michael E ^a   Sailer, Scott L ^a   Rosenman, Julian G ^a   Tepper, Joel E ^a   Weissler, Mark C ^a   Shockley, William W ^a   Yarbrough, Wendell G ^a   Pillsbury III, Harold C ^a   Schell, Michael J ^b   Bernard, Stephen A ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; FLUOROURACIL;

ADULT; AGED; ARTICLE; BEAM THERAPY; CANCER PALLIATIVE THERAPY; CANCER REGRESSION; CANCER STAGING; CANCER SURVIVAL; CERVICAL LYMPH NODE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HEAD AND NECK CARCINOMA; HUMAN; LYMPH NODE METASTASIS; MALE; MUCOSA INFLAMMATION; NEPHROTOXICITY; NEUTROPENIA; ORGAN PRESERVATION; RADIATION DOSE; SQUAMOUS CELL CARCINOMA; TREATMENT OUTCOME;

EID: 0035216986     PISSN: 08864470     EISSN: None     Source Type: Journal    
DOI: 10.1001/archotol.127.12.1446     Document Type: Article

References (10)

1. Head and neck
2. Neoplasms of the head and neck
3. Overview of platinum chemotherapy in head and neck cancer
4. A phase III randomized study comparing cisplatin and fluorouracil as single agents and in combination for advanced squamous cell carcinoma of the head and neck
5. Concomitant chemoradiotherapy: Rationale and clinical experience in patients with solid tumors
6. Recent randomized trials of chemoradiation in the management of locally advanced head and neck cancer
7. A phase III randomized trial comparing concurrent chemotherapy and radiotherapy with radiotherapy alone in resectable stage III and IV squamous cell head and neck cancer: Preliminary results
8. Simultaneous radiochemotherapy versus radiotherapy alone in advanced head and neck cancer: A randomized multicenter study
9. Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer